The Care Tracker Study: Using Patient-Reported Data to Address Racial Disparity in Cancer Treatment

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

240 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-11-06

Study Completion Date

2026-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study assesses the feasibility and acceptability of a brief electronic patient-reported outcome (ePRO) tool that allows patients to self-identify impending delays. The risk of treatment delays according to tumor type and race will be measured by both ePRO and electronic health record (EHR) tools. Data from this study and the association of social determinants of health could be useful to flag patients at risk of delay and due timely intervention for modifiable treatment barriers. The prediction of the risk of treatment delay will be helpful to design another study using electronic tracking systems to prevent cancer treatment delays. The long-term goal of this research is to alert care teams when patients may be at risk of treatment days and to help patients get treatment faster. It was planned to enroll a total of 240 subjects with newly diagnosed cancer. Sixty colorectal and 180 breast cancer patients will be included.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Accountability for Cancer Care Through Undoing Racism and Equity

NCT01954641

Breast Cancer Lung Cancer

COMPLETED NA

Metastatic Breast Cancer-Specific Prognostic Tool

NCT05574478

Metastatic Breast Cancer

COMPLETED

Nurse-led Proactive Telephone Follow-up With Patients After Completion of Primary Cancer Treatment

NCT06223022

Breast Cancer Colorectal Cancer Prostate Cancer

ENROLLING_BY_INVITATION NA

Peer Navigator Education in Improving Survivorship Care in African American Breast Cancer Survivors

NCT01450020

Breast Cancer

ACTIVE_NOT_RECRUITING NA

Improving Survivorship Among Minority Cancer Dyads

NCT04685551

Cancer Breast Cancer Colon Cancer +2 more

WITHDRAWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer Breast Cancer Colorectal Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

electronic patient-reported outcome (ePRO) questionnaires.

Subjects with colon or breast carcinoma will respond to weekly electronic patient-reported outcome (ePRO) questionnaires.

Group Type EXPERIMENTAL

Weekly Survey

Intervention Type BEHAVIORAL

Subjects will respond to Electronic patient-reported outcome (ePRO) every week for 8 weeks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Weekly Survey

Subjects will respond to Electronic patient-reported outcome (ePRO) every week for 8 weeks.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

In order to participate in this study a subject must meet all of the eligibility criteria outlined below.

1. Male and female patients of age \>18 years.
2. Pathologic diagnosis of breasts or colorectal cancer within 6 weeks (42 days) prior to the enrollment date.
3. Have not yet initiated cancer treatment on the date of enrollment.
4. Indicate intent to receive cancer treatment at the University of North Carolina.

Exclusion Criteria

1. Patient unwilling or unable to receive electronic survey links via email or text link on a mobile device, tablet, laptop, or desktop computer.
2. Patient unwilling or unable to provide verbal or signed consent to participate.
3. Patient cannot read and speak English.
4. Patients who do not have email access or a smartphone are able to receive Short Message/Messaging Service (SMS) text messages.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No